Sanofi India share news, announcements and annual reports
NSE: SANOFIBSE: 500674Pharmaceuticals & BiotechnologySmall Cap
Sanofi India Limited · Formerly Aventis Pharma · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1984 on BSE, May 2003 on NSE
Last close ₹3,204.10up ₹14.60 (0.46%)BSE ₹3,204.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,189.50.
30 Oct: open ₹3,265.00, high ₹3,422.60, low ₹3,175.10
52-week range of traded prices to 30 Oct 2026
₹2,758.20Low, 23 Oct 2026₹4,834.00High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,379 Cr614th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.93
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.84%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 45.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 57.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Jun 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,04,44220.0% delivered
Sanofi India shareholding disclosures
27 filed, newest first.
Oct 2026
Sep 2026
Jun 2026
Jun 2025
Jan 2025
Jan 2024
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Apr 2017
Apr 2015
Feb 2015
Jan 2013
Mar 2010
22 Mar · Disclosure
"Hoechst GmbH, a 100% subsidiary of Sanofi-aventis S.A., has decided to increase its equity shareholding in Aventis Pharma Limited by offering to purchase 2,366,380 equity shares representing 10.27% of share capital of Aventis Pharma Limited from other "qualifying promoters" of Aventis Pharma Limited (comprising of United Breweries (Holding) Limited, Kingfisher Finvest India Limited, McDowell Holdings Limited and Mallya Private Limited) as inter-se transfer amongst the qualifying promoters at a price of Rs.1,750/- per equity share. This offer satisfies all the tests prescribed under the SAST Regulations for being regarded as an inter-se transfer amongst the qualifying promoters and is eligible for exemption from an open offer obligation to the minority shareholders of Aventis Pharma Limited". The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2010
5 Feb · Disclosure
Aventis Pharma Limited had informed the Exchange regarding disclosures in respect of the reduction in shareholding of 2% in the Company of UTI Mutual Fund consequent on aggregate sale of 505,463 Shares from August 18, 2005 to December 11, 2009. The Company has now informed the Exchange that the figures furnished by the Company in Form C were based on figures furnished to the Company by UTI Mutual Fund. Further, the Company has informed the Exchange that "It has been pointed out to us that the figures given in Form C were not correct. We accordingly took up the matter with UTI Mutual Fund and they have clarified that they had omitted 201 Shares in their disclosures to us". Further, in view of the revised figures furnished by UTI Mutual Fund, the Company has submitted to the Exchange revised Form C. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
4 Jan · Disclosure
(1) Disclosure in terms of Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992; (2) Disclosure in terms of Regulation 7(3) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. The copies of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
18 Feb · Disclosure
Disclosure pursuant to Regulation 8A(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) (Amendment) Regulations, 2009. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.